HKHyunju Kim

Hyunju Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hyunju Kim has a total of 265 co-authors. Here are the top co-authors by number of shared publications:

  • Casey M. Rebholz

    Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD, USA

    25 shared publications
  • Casey M. Rebholz

    Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA

    10 shared publications
  • Josef Coresh

    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Optimal Aging Institute and Division of Epidemiology, Department of Population Health, New York University Grossman School of Medicine, New York, NY, United States

    9 shared publications
  • Casey M Rebholz

    Department of Pediatrics, New York University Grossman School of Medicine, New York, NY, United States; Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD, United States

    7 shared publications
  • Jihye Kim

    Department of Genetics and Biotechnology, College of Life Sciences, Kyung Hee University, Yongin 17104, Republic of Korea

    6 shared publications
  • Lyn M. Steffen

    Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota

    6 shared publications

Latest Publications

  • Metabolomic biomarkers of ultraprocessed food intake and their associations with all-cause mortality in the Chronic Renal Insufficiency Cohort (CRIC)

    by Valerie K. Sullivan, Jingsha Chen, Hyunju Kim, Lawrence J. Appel, Ana Ricardo, Eugene P. Rhee, Ramachandran S. Vasan, Hernan Rincon-Choles, James P. Lash, Nishigandha Pradhan, et al.

  • Associations of Plant- and Animal-Sourced Ultra-Processed Foods and Incident CKD in the Cardiovascular Health Study

    by Courtney M. Hill, Alyssa Feinberg, Casey M. Rebholz, Rozenn Lemaitre, Amanda M. Fretts, Kerri L. Wiggins, Nona Sotoodehnia, James S. Floyd, Benjamin Lidgard, Nisha Bansal, et al.

    Key Points: Ultraprocessed foods are associated with incident CKD. Whether sources of ultraprocessed foods (plant or animal) are related to incident CKD remains unknown. In 2661 older adults, total, plant-, and animal-sourced ultraprocessed foods were associated with incident CKD, but associations were weaker for plant-sourced ultraprocessed foods. It is important to consider future studies to investigate whether altering processing levels in plant foods can prevent CKD. Background: Ultraprocessed foods (UPFs) are associated with adverse health. Plant foods can be highly processed. It is not clear whether plant- and animal-sourced UPFs are associated CKD risk. Methods: Data came from the Cardiovascular Health Study, a prospective cohort of 2661 adults aged 65 years and older. The exposure was UPF intake, classified as plant or animal sourced in servings/d using the Nova framework from food frequency questionnaires (1989–1990 and 1995–1996). The outcome was incident CKD (eGFR 2 ) and absolute eGFR change (up to 18 years). Time-dependent Cox and linear models were used to examine the associations between total, plant-, and animal-sourced UPF and minimally processed food (MPF) intake with incident CKD and eGFR change. Results: After a median 6.8 years of follow-up and adjusting for demographics and health behaviors, those in the highest tertiles of total and animal-sourced UPF intake had 26% and 37% higher risk of incident CKD compared with the lowest tertile (hazard ratio [HR], 1.26; 95% confidence interval [CI], 1.08 to 1.47; P trend = 0.003 and HR, 1.37; 95% CI, 1.17 to 1.60; P trend < 0.001, respectively). Per SD higher plant-sourced UPF was associated with higher CKD risk (HR, 1.07; 95% CI, 1.01 to 1.13) but not in categorical analyses ( P trend = 0.12). Higher total MPF was associated with 20% lower risk of incident CKD (HR, 0.80 for tertile 3 versus 1; 95% CI, 0.69 to 0.95; P trend = 0.008). Replacing 3 servings of total MPF with total UPF (HR, 1.02; 95% CI, 1.001 to 1.03, P = 0.04) and plant-sourced MPF with plant-sourced UPF (HR, 1.02; 95% CI, 1.002 to 1.05, P = 0.03) was weakly associated with elevated risks of CKD. No associations were observed for eGFR change. Competing-risk analyses for mortality attenuated estimates. Conclusions: Total and animal-sourced UPFs were associated with incident CKD, and plant-sourced UPF was modestly associated with incident CKD. Health benefits of plant foods may be dampened by ultraprocessing, but additional work is needed in younger populations.

  • Open Access

    Circulating proteins altered in response to the Dietary Approaches to Stop Hypertension (DASH) diet suggest underlying molecular mechanisms and long-term health benefits

    by Hyunju Kim, Jennifer A. Brody, Guanghao Qi, Ting Ye, Rizwan Kalani, Lawrence J. Appel, Casey M. Rebholz, Neil M. Davies, James S. Floyd

    The Dietary Approaches to Stop Hypertension (DASH) diet reduces blood pressure and cholesterol. However, the mechanisms underlying these effects are unclear, and no randomized studies have evaluated the long-term benefits on health outcomes such as coronary artery disease (CAD) or type 2 diabetes (T2D). We performed a series of Mendelian randomization analyses of 71 serum proteins perturbed by the DASH diet in previous randomized controlled feeding studies to understand their potential mechanistic role on health outcomes. Four proteins (ANGPTL3, INHBC, PCOLCE, PLXNB2) had causal evidence of beneficial effects on risk factors that aligned with diet-induced changes in protein levels. Missense variants in INHBC and PLXNB were associated with lower risks of CAD and T2D respectively, and these effects are directionally concordant with DASH diet-induced changes in protein levels, providing causal evidence that these proteins influence disease risk. Combining molecular phenotyping in randomized interventional studies with human genetics evidence identified molecular regulators of the long-term cardioprotective effects of the DASH diet.

  • Open Access

    Plasma Proteins Associated with Whole Grains and Fiber Intake in the Cardiovascular Health Study (CHS) and the Atherosclerosis Risk in Communities (ARIC) Study

    by Alyssa Feinberg, Thomas R Austin, Ana Gabriela Vasconcelos, Jennifer A Brody, Kerri L Wiggins, Rozenn N Lemaitre, Amanda M Fretts, Denise C Hasson, Nona Sotoodehnia, James S Floyd, et al.


  • Open Access

    Association of a Comprehensive Healthy Lifestyle Score with Risk of All-Cause, Cancer, and Cardiovascular Mortality: Evidence from an 18-Year Cohort Study

    by Dongmin Kim, Daeyun Kim, Hyunju Kim, Jihye Kim

    Background/Objectives: Comprehensive management of lifestyle factors is important for long-term survival. This study aims to examine whether a comprehensive healthy lifestyle score (HLS) incorporating overall diet assessment predicts all-cause, cancer, and cardiovascular mortality in Korean population. Methods: This prospective cohort study was conducted among men and women (n = 111,633, 64.6% women) aged 40 to 85 years who participated in the Korean Genome and Epidemiology Study_Health Examinees (Mean age = 55.2, SD = 8.8). Participants completed a baseline questionnaire between 2004 and 2013 and were followed until December 2023. The HLS consisted of five components classified as healthy behaviors: never or former smoking; engaging in ≥30 min/day of moderate-to-vigorous physical activity on ≥5 days/week; alcohol intake ≤40 g/day for men and ≤20 g/day for women; a BMI of 18.5–24.9 kg/m2; and an unhealthful plant-based diet index (uPDI) in the bottom 40th percentile, which reflects overall diet quality and aligns with the traditional plant-rich dietary pattern of Koreans. Diet was assessed using data from baseline and the first follow-up, while the remaining components were measured at baseline only. Cox proportional hazards models were applied to evaluate multivariable-adjusted associations between the HLS and all-cause, cancer, and cardiovascular mortality. Results: During 1,538,490 person-years of follow-up, 5246 all-cause deaths, 2362 cancer deaths, and 815 cardiovascular deaths were documented. Compared with the lowest HLS category, men with the highest HLS had lower risks of all-cause (HR: 0.65, 95% CI: 0.53–0.80), cancer (HR: 0.62, 95% CI: 0.46–0.85), and cardiovascular mortality (HR: 0.34, 95% CI: 0.17–0.66). Among women, the corresponding HRs were 0.38 (95% CI: 0.26–0.55), 0.52 (95% CI: 0.29–0.90), and 0.30 (95% CI: 0.11–0.84), respectively. The inverse association was stronger in older adults (≥55 years) than in younger adults. All five individual lifestyle components, including diet (quintile 5 vs. quintile 1 of uPDI: HR 0.74, 95% CI: 0.66–0.83 in men; HR 0.67, 95% CI: 0.58–0.76 in women), were significantly associated with a lower risk of all-cause mortality. However, when smoking was excluded from the HLS, the inverse association was attenuated, particularly among men. Conclusions: Greater adherence to a healthy lifestyle score was strongly associated with reduced risks of all-cause, cancer, and cardiovascular mortality. These findings underscore the importance of promoting integrated, multi-behavior lifestyle interventions, especially smoking cessation, to reduce premature mortality.


  • Open Access

    Plant-based dietary patterns are associated with slower epigenetic aging

    by Hyunju Kim, Christina A. Castellani, Jiantao Ma, Alexis C. Wood, Audrey Ting, Morgan E. Grams, Bing Yu, Kelly Ruggles, James S. Floyd, Dan E. Arking, et al.

    Greater adherence to plant-based diets is associated with health benefits. Dietary intake can modify DNA methylation patterns, but it is unknown whether plant-based diets in a largely non-vegetarian population are associated with DNA methylation-based epigenetic aging measures. We examined the associations between 4 different types of plant-based diets indices (PDI) [overall PDI, provegetarian diet, healthy PDI, and unhealthy PDI] and epigenetic aging. We used data from the Atherosclerosis Risk in Communities (ARIC) Study (N=2,810) and National Health and Nutrition Examination Survey (NHANES, N=2,056). PDIs negatively scored higher intake of animal products and positively scored higher intake of all or selected plant foods (overall PDI and provegetarian diet), healthy plant foods (healthy PDI), and unhealthy plant foods (unhealthy PDI). Associations were examined with GrimAge version2, HannumAge, and PhenoAge in each study. Estimates were meta-analyzed using fixed effects model. Each standard deviation (SD) higher in the overall PDI, provegetarian diet, and healthy PDI was associated with decelerated GrimAge2 (range of β = -0.28 to -0.16, P for all tests <0.05). Higher overall PDI and provegetarian diet was associated with decelerated PhenoAge and HannumAge (overall PDI only). No significant association was observed for unhealthy PDI. Following diets rich in plant foods and low in animal products may slow biological aging.


  • Open Access

    Association of plant-based diets with subclinical cardiovascular disease in U.S. adults, 1999-2004

    by Audrey Ting, Amelia S. Wallace, Mary R. Rooney, Hyunju Kim, Valerie K. Sullivan, Elizabeth Selvin, Casey M. Rebholz


  • Open Access

    Menstrual disturbance associated with COVID-19 vaccines: A comprehensive systematic review and meta-analysis

    by Kunchok Dorjee, R. C. Sadoff, Farima Rahimi Mansour, Sangyal Dorjee, Eli M. Binder, Maria Stetson, Regina Yuen, Hyunju Kim

    Background: The relationship between COVID-19 vaccines and menstrual disturbance is unclear, in part because researchers have measured different outcomes (e.g., delays vs. changes to cycle length) with various study designs. Menstrual disruption could be a decisive factor in people’s willingness to accept the COVID-19 vaccine. Methods: We searched Medline, Embase, and Web of Science for studies investigating menstrual cycle length, flow volume, post-menopausal bleeding, and unexpected or intermenstrual bleeding. Data were analyzed using fixed-effects meta-analysis with Shore’s adjusted confidence intervals for heterogeneity. Findings: Seventeen studies with >1·9 million participants were analyzed. We found a 19% greater risk of increase in menstrual cycle length as compared to unvaccinated people or pre-vaccination time-periods (summary relative risk (sRR): 1·19; 95% CI: 1·11–1·26; n = 23,718 participants). The increase in risk was the same for Pfizer-BioNTech (sRR: 1·15; 1·05–1·27; n = 16,595) and Moderna vaccines (sRR: 1·15; 1·05–1·25; n = 7,523), similar for AstraZeneca (sRR: 1·27; 1·02–1·59; n = 532), and higher for the Janssen (sRR: 1·69; 1·14–2·52; n = 751) vaccine. In the first cycle after vaccination, length increased by <half-day (summary mean difference (sMD): 0·34 days; 0·21–0·46 days; n = 30,320) after the first dose and by 0·62 days (sMD: 0·62: 0·41–0·82; n = 17,608) after the second dose. In the second cycle after vaccination, the risk was not elevated (sMD: –0·02; –0·16–0·12; n = 18,602). The increase in risk was between 7–9% but statistically insignificant for heavier flow; 7% for post-menopausal bleeding (first dose: 1·07; 1·01–1·12; n = 1,321,268 and second dose: 1·07; 1·03–1·11; n = 1,482,884); and 16–41% for unexpected or intermenstrual bleeding (first dose: 1·16; 0·83–1·61; n = 1,303,687 and second dose: 1·41; 0·99–2·01; n = 1,390,317). Interpretation: We observed a mild increase in the risk of menstrual disturbance associated with COVID-19 vaccines. Such risks are likely clinically unmeaningful. Vaccine recipients should be appropriately counseled.